- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06288919
Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Crowns Made by Different Materials
Erythritol vs Ultrasonic Scaler Prophylaxis Systems on Dental Implants With Different Types of Crowns: Randomized Clinical Trial
The aim of the study is to assess which prophylaxis methods is the most suitable for peri-implant hygiene between erythritol and ultrasonic scaler with peek inserts.
A randomized clinical trial will be conducted on the patient. Patients will be randomly divided into two groups:
- Erythritol group: erythritol with a particle size of ~14 µm will be used for 5 seconds (AIRFLOW® PLUS EMS)
- Ultrasonic scaler group: a piezoelectric handpiece with peek inserts (Mini Piezon EMS; PI EMS) will be used.
Different subgroups will be defined according to the material of the dental crown of the related implant.
The oral hygiene session will be carried out every 6 months (2-years follow-up; 6 sessions), after instruction and motivation of the patient, completion of the clinical chart with the recording of the Probing Depth (evaluation in mm of the peri-implant sulcus taken by a periodontal probe; 4 surfaces of the gingival margin are detected: vestibular, palatal/lingual, mesial, distal), Bleeding on Probing and Plaque Index.
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of the study is to assess which prophylaxis methods is the most suitable for peri-implant hygiene between erythritol and ultrasonic scaler with peek inserts.
A randomized clinical trial will be conducted on the patient. Patients will be randomly divided into two groups:
- Erythritol group: erythritol with a particle size of ~14 µm will be used for 5 seconds (AIRFLOW® PLUS EMS)
- Ultrasonic scaler group: a piezoelectric handpiece with peek inserts (Mini Piezon EMS; PI EMS) will be used.
Different subgroups will be defined according to the material of the dental crown of the related implant: feldspathic ceramic, zirconia and lithium disilicate.
The oral hygiene session will be carried out every 6 months (2-years follow-up; 6 sessions), after instruction and motivation of the patient, completion of the clinical chart with the recording of the Probing Depth (evaluation in mm of the peri-implant sulcus taken by a periodontal probe; 4 surfaces of the gingival margin are detected: vestibular, palatal/lingual, mesial, distal), Bleeding on Probing and Plaque Index.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Andrea Scribante, DDS, PhD, MS
- Phone Number: +39 0382516223
- Email: andrea.scribante@unipv.it
Study Locations
-
-
Lombardy
-
Pavia, Lombardy, Italy, 27100
- Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18 and 70
- Presence of at least one dental implant
- Good compliance
Exclusion Criteria:
- Patients with cardiac stimulators
- Patients with neurological disorders
- Patients with psychological disorders
- Pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Erythritol group
|
erythritol with particle size of ~14 µm will be used for 5 seconds (AIRFLOW® PLUS EMS)
|
Active Comparator: Ultrasonic scaler
|
ultrasonic scaler, a piezoelectric handpiece with peek inserts (Mini Piezon EMS; PI, EMS) will be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Probing Depth (PD)
Time Frame: Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
Evaluation in mm of the peri-implant sulcus taken by a periodontal probe.
4 surfaces of the gingival margin are detected: vestibular, palatal/lingual, mesial, distal.
|
Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
Bleeding on Probing (BoP)
Time Frame: Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
Evaluation of the presence or absence of gingival bleeding during a probing
|
Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
Plaque Index
Time Frame: Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
evaluation of the amount of soft deposits on implant surfaces at each session.
|
Baseline (T0), 6 months (T1), 12 months (T2), 18 months (T3) 24 months (T4)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andrea Scribante, DDS, PhD, MS, University of Pavia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-IMPLHYGIENE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on Erythritol prophylactic powders
-
Mahidol UniversityCompletedStain Removal EfficacyThailand
-
University Hospital, Basel, SwitzerlandCompletedPhysiological Satiation MechanismsSwitzerland
-
Chiang Mai UniversityKagawa UniversityUnknown
-
CargillBiofortis Mérieux NutriSciencesCompletedTolerance | GastrointestinalFrance
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, Basel, SwitzerlandRecruitingInsulin Resistance | Body Composition | Glucose Tolerance | Gastrointestinal Tolerance | Thrombocyte Aggregation | Blood p-Selectin | Blood ErythritolSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedPhysiological Satiation MechanismsSwitzerland
-
Azienda Socio Sanitaria Territoriale degli Spedali...Università degli Studi di FerraraCompletedPeriodontitis, Aggressive | Periodontitis, AdultItaly
-
University Hospital, Basel, SwitzerlandCompleted
-
Boston UniversityCargillCompletedType 2 Diabetes MellitusUnited States